VOYAGER THERAPEUTICS INC (VYGR)

US92915B1061 - Common Stock

8.63  +0.06 (+0.7%)

After market: 8.55 -0.08 (-0.93%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
250.01M40.90M37.40M171.10M104.40M
Operating Expenses
127.99M91.70M111.00M143.70M156.10M
Research and Development
92.17M60.80M73.80M108.80M119.70M
Selling, General, and Administrative Expenses
35.82M31.00M37.20M35.00M36.30M
Operating Income
122.01M-50.80M-73.60M27.40M-51.70M
Interest Income/Expense
11.72M1.80M-400.00K1.70M6.50M
Other Income/Expense
3.00K2.70M2.80M7.70M1.60M
Income Before Taxes
133.74M-46.40M-71.20M36.70M-43.60M
Income Tax
1.41M0.00N/A0.000.00
Net Income
132.33M-46.40M-71.20M36.70M-43.60M
EBITDA
126.45M-44.61M-68.43M31.22M-48.93M
 
Per Share Data
EPS Diluted Total Ops
2.97-1.21-1.890.98-1.21
Non GAAP EPS
3.09-1.22-1.900.95-1.27
 
Statistics
Profit Margin
52.93%-113.45%-190.37%21.45%-41.76%
Operating Profit Margin
48.80%-124.21%-196.79%16.01%-49.52%

All data in USD

Charts